Analytical Data
-
Gene name
MAPRE1
- Application
-
Alternative Names
EB1; Adenomatous Polyposis Coli-Binding protein; APC-binding protein EB1; End-binding protein 1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15691
-
Expression Region
Ala2~Tyr268
-
Molecular Weight
34kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAPRE1 (Microtubule-Associated Protein RE1) is a member of the MAPRE family, which plays a crucial role in microtubule dynamics and cellular processes such as mitosis and intracellular transport. Recent studies have indicated that MAPRE1 is involved in cancer pathology, where its expression levels correlate with tumor progression and patient prognosis. The protein is also linked to various neurodegenerative disorders, suggesting its importance in neuronal integrity and function. Researchers have begun exploring MAPRE1 as a potential therapeutic target due to its pivotal role in microtubule stability and cell proliferation. Furthermore, its interactions with other key proteins, including those involved in signaling pathways and cytoskeletal organization, highlight its significance in maintaining cellular homeostasis. Understanding the structure, function, and regulatory mechanisms of MAPRE1 could provide insights into its potential applications in targeted therapies for cancer and neurodegenerative diseases. Given these implications, the study of MAPRE1 recombinant protein is essential for elucidating its biological functions and therapeutic potential, paving the way for novel intervention strategies in related diseases.
